Literature DB >> 28681023

Characterization and identification of candiduria due to Candida species in diabetic patients.

M Falahati1, S Farahyar1, L Akhlaghi1, Sh Mahmoudi2,3, K Sabzian4, M Yarahmadi2,5, R Aslani1.   

Abstract

BACKGROUND AND
PURPOSE: The presence of Candida yeasts in urine, known as candiduria, is an indicator of infection or colonization of the urinary tract by Candida species. This condition in diabetic patients can be hazardous due to diminished immune system response. The objective of this study was to investigate the incidence of candiduria in diabetic patients and to identify its causative agents. Furthermore, the demographic and laboratory (HbA1c, urine glucose and pH, urine culture colony count, and fasting blood sugar) data and their possible associations with candiduria were investigated.
MATERIALS AND METHODS: This cross-sectional, descriptive study was performed on 305 diabetic patients referred to the diabetes research center, Hamedan, Iran, during April 2015 to September 2015. Urine and blood specimens were collected and urine analysis, urine culture, FBS, and HbA1c tests were performed. Positive cases were subjected to colony count and the causative agents were subsequently identified through the routine identification tests, as well as colony color in CHROMagar Candida medium, and the assimilation patterns in API 20 C auxanographic method.
RESULTS: Among the 305 cases, 38 (%12.5) were positive for candiduria. Causative agents were identified as Candidaglabrata (n=19, 50%), C. albicans (n=12, 31.6%), C. krusei (n=4, 10.5%), C. tropicalis (n=2, 5.3%), andC. kefyr (n=1, 2.6%). According to the results of the statistical analyses, there were significant association between candiduria and female gender, high FBS and urine glucose, uncontrolled diabetes (HbA1c ≥8), and acidic urine pH (P<0.05).
CONCLUSION: Considering the high incidence rate of candiduria in diabetic patients, control of diabetes, predisposing factors, and causal relationships between diabetes and candiduria should be highlighted.

Entities:  

Keywords:  Candida; Diabetes; HbA1c; Urinary tract infections

Year:  2016        PMID: 28681023      PMCID: PMC5490284          DOI: 10.18869/acadpub.cmm.2.3.10

Source DB:  PubMed          Journal:  Curr Med Mycol        ISSN: 2423-3420


Introduction

Candida species are the most frequently recovered fungi from genital and urinary tract. Candiduria, which means the presence of Candida in urine, is caused by albicans and non-albicans species of the genus Candida. Identification of Candida isolates to the species level is required due to changes in dominant species and different antifungal susceptibility patterns observed in recent years [1, 2]. Broad- spectrum antibiotic therapy, application of catheters, endocrine disorders such as diabetes mellitus, prolonged hospitalization, primary or secondary weakness in immune system responses, and urinary system disorders and abnormalities are some of the common predisposing factors of candiduria [3]. Although the presence of Candida in urine may be a transient and asymptomatic condition and may not meet the typical requirements for systemic antifungal therapy [4], the high risk of morbidity and mortality associated with candiduria in immunocompromised individuals highlights the clinical importance of this condition [5]. Diabetes is the most common endocrine disorder worldwide. Owing to immunologic impairments following diabetes, it is a potent predisposing factor for a wide spectrum of infections. Patients with uncontrolled diabetes and high levels of blood sugar (hyperglycemia) leave the integumentary system, gastrointestinal and urinary tracts, and mucous membranes more susceptible to infectious agents due to reduced immunity of the body [6-8]. Urinary tract infection (UTI) is a frequent condition in diabetic individuals, and candiduria could be the onset of a disseminated infection [9, 10]. According to these data, investigation of the dominant Candida species and the relationships between candiduria and underlying factors seems imperative for effective prevention of severe consequences of disseminated Candida infections. The objective of this study was to investigate the incidence of candiduria in diabetic patients in Hamedan, Iran, and to identify its causative agents. Furthermore, we aimed to investigate the associations between candiduria and demographics, laboratory values (such as glycated hemoglobin [HbA1c], urinary glucose/pH, urinary culture colony count, and FBS) data.

Materials and Methods

In this cross-sectional, descriptive study, performed during a six-month period (from April 2015 to September 2015), a total of 305 diabetic outpatients (age range: 17-74 years) of a referral diabetes research center in Hamedan, Iran, were included. Lack of any other predisposing and confounding factors such as vaginitis was the inclusion criterion. Demographic data and informed consent were obtained from all the patients and this study was approved by the Ethics Committee of Iran University of Medical Sciences, Tehran, Iran (Code IR.IUMS.REC.1395.861066003). Clean catch midstream urine and venous blood specimens were collected from all the patients. Routine urine analysis, urine glucose test, and urine culture were performed on all the specimens and positive cases were subjected to culture colony count. Isolated Candida species were identified by routine laboratory tests, colony color in CHROMagar candida medium (CHROMagar, France), and the assimilation patterns in API 20C auxanographic method (bioMerieux, Marcy l’Etoile, France). FBS and HbA1c tests were performed using an automated biochemical analyzer (BT 1500, Biotecnica Instruments, Italy) on the serum specimens of the patients. The results of all the tests and demographic data were analyzed using Chi-square test and t-test in SPSS, version 15.

Results

Among the 305 studied cases consisting of 223 females (73.1%) and 82 males (26.9%), 38 patients (12.5%) were positive for candiduria. Of these patients, 30 (9.8%) had colony count ≥ 103. According to the statistical analysis, there was a significant association between female gender and candiduria (P=0.005). C. glabrata was the most common cause of candiduria accounting for half of the cases in this study followed by C. albicans. The frequency of different Candida species in this study is presented in Table 1.
Table 1

The frequency of Candida species isolated from urine specimens of diabetic patients

Candida speciesTotal
FrequencyPercentage
C. glabrata 1950
C. albicans 1231.6
C. krusei 410.5
C. tropicalis 25.3
C. kefyr 12.6
total38100
The frequency of Candida species isolated from urine specimens of diabetic patients The mean colony count of Candida species among 38 positive cases was 5.37×104 CFU/ml with the minimum and maximum values of 2×102 and 5.8×105 CFU/ml, respectively. The urine pH varied from 5 to 8 among all the patients, and the majority of candiduria cases were within the pH range of 5-6. A statistically significant association was observed between acidic urine pH and the occurrence of candiduria (P=0.02). High FBS values (P=0.001), glucosuria (P=0.022), and uncontrolled diabetes (HbA1c≥8; P=0.001) also significantly associated with candiduria in the present study. Table 2 demonstrates the frequency of candiduria in the study population based on different characteristics of the patients.
Table 2

Distribution of candiduria among diabetic patients based on different variables

VariablesCandiduria
Total
NegativePositive
Gender
Male79382
Female18835223
Total 26738305
Marital status
Single 18018
Married 21629245
Divorced 33942
Total 26738305
Diabetes type
I25429
II24234276
Total 26738305
CFUa
0 2670267
1-103088
103-10401616
104-10501010
105-106044
Total 26738305
Urine pH
5-623437271
6-7< 22123
>7-811011
Total 26738305
FBSb
50-1501357142
151-25010620126
251-350231033
351-450314
Total 26738305
HbA1cc
<817613189
≥89125116
Total26738305

. Colony forming unit/ml

Fasting blood sugar (mg/dl)

. Hemoglobin A1c (% of total Hemoglobin)

Discussion

Candida species are the leading fungal agents of UTI, particularly in patients with deficient immune responses [11]. The majority of candiduria cases are acquired as nosocomial infection due to application of catheters and wide spectrum antibiotic therapy [12]. Candida species are the causative agents of up to 10% of all nosocomial UTI cases [13], and some underlying factors such as advancing age, female gender, antimicrobial therapy, urinary catheter, surgery, and diabetes mellitus may facilitate their pathogenesis [14]. Also, biofilm formation, adhesion of fungi to the host tissue and medical devices, and extracellular hydrolytic enzymes production are considered as factors facilitating the commensal to pathogen shift of Candida species [15]. The recovery rate of Candida species from urine samples varies in different studies. In the present study, 38 out of 305 patients (12.5%) were positive for candiduria, and among them, 30 (9.8%) had significant candiduria (≥103 CFU/ml). In a study conducted by Nademi et al. [11], nosocomial candiduria was reported in 4.3% (5 out of 115) of hospitalized patients. Furthermore, Yismaw et al. [10] reported significant candiduria in 7.5% and 17.1% of asymptomatic and symptomatic patients with diabetes, respectively. The overall candiduria rate was 8.3% (35 out of 422). Similarly, Goyal et al. [2], Zarei et al. [16], and Padawer et al. [17] reported candiduria in 2.36%, 16.5%, and 19.49% of their study populations, respectively. In a comparative study by da Silva Krenke et al. [18], candiduria was reported in 30% and 16% of diabetic and non-diabetic patients, respectively. The disagreements between the results of various studies may be due to differences in study populations, underlying factors, preventive measures of patients and hospitals, and geographical location. Distribution of candiduria among diabetic patients based on different variables . Colony forming unit/ml Fasting blood sugar (mg/dl) . Hemoglobin A1c (% of total Hemoglobin) Although C. albicans is reported as the major Candida species causing candiduria in some studies [3, 16, 19, 20], an increasing trend in the prevalence of candiduria due to non-albicans Candida species was shown by some researchers [2, 21-23]. In the present study, C. glabrata was the most isolated species (50%) followed by C. albicans (31.6%), C. krusei (10.5%), C. tropicalis (5.3%), and C. kefyr (2.6%). The higher incidence of non-albicans Candida species, including C. glabrata, may be due to their ability to adapt to the urinary tract condition, as well as their intrinsic and/or acquired resistance to the conventional antifungals [2]. Considering the high drug resistance of non-albicans Candida species, especially C. glabrata [2, 22], their dominance should be considered as a health concern and a probable cause of treatment failure. The association between candiduria and different demographic and laboratory data was assessed in the present study. Female gender, decreased (acidic) urine pH, high FBS followed by glucosuria, and uncontrolled diabetes (HbA1c ≥8) were associated with candiduria. Although the urine pH of diabetic cases was within the range of 5-8, all the cases of candiduria had acidic pH. Acidic pH is favorable for Candida species and alkaline pH decreases their growth. Strassner et al. [24] used potassium-sodium-hydrogen citrate for alkalinization of urine in patients with candiduria as a treatment technique. In so doing, candiduria disappeared in 89% (16 out of 18) of patients. In agreement with the findings of the present study, Paul et al. reported high plasma glucose level as a correlated factor to the candiduria [13]. Also Geerlings et al. [25] believed that female gender, poor or uncontrolled diabetes (HbA1c ≥8), and some other factors like pregnancy, aging, and a history of UTI within the previous six months are the possible risk factors for candiduria in diabetic patients. According to the data from a study conducted by Georgiadou et al. [23], female gender, multiple hospitalization, broad-spectrum antimicrobial the-rapy, renal dysfunction, intensive care unit admission, and diabetes mellitus are predisposing factors of candiduria in patients with hematologic malignancy. In addition to urinary system disorders following candiduria, candidemia is reported to be significantly associated with the candiduria [26], which underscores the importance of this condition. The present study was conducted in a referral center for diabetes in Hamedan, Iran. The results provided an update to the dominant Candida species in Hamedan and highlights the possibility of treatment failure due to high resistance of non-albicans Candida species. However, it is recommended to perform further studies with larger sample sizes and susceptibility testing to determine the efficient antifungal agents.

Conclusion

Considering the high incidence rate of candiduria in diabetic patients, efficient control of diabetes, predisposing factors, and causal relationships between diabetes and candiduria should be emphasized. In addition, as the non-albicans Candida species were isolated more than C. albicans, their intrinsic resistance to antifungal drugs should be noted. Antifungal susceptibility testing for determination of susceptibility/resistance profile of isolates could be helpful for appropriate treatment.
  23 in total

1.  Candiduria.

Authors:  Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2005-09-15       Impact factor: 9.079

2.  Correlation between candiduria and departmental antibiotic use.

Authors:  M Weinberger; S Sweet; L Leibovici; S D Pitlik; Z Samra
Journal:  J Hosp Infect       Date:  2003-03       Impact factor: 3.926

3.  [Therapy of candiduria by alkalinization of urine. Oral treatment with potassium-sodium-hydrogen citrate].

Authors:  C Strassner; A Friesen
Journal:  Fortschr Med       Date:  1995-09-10

4.  Biofilm formation by and antifungal susceptibility of Candida isolates from urine.

Authors:  N Jain; R Kohli; E Cook; P Gialanella; T Chang; B C Fries
Journal:  Appl Environ Microbiol       Date:  2007-01-19       Impact factor: 4.792

5.  Investigation of the possible association between nosocomial candiduria and candidaemia.

Authors:  C A Binelli; M L Moretti; R S Assis; N Sauaia; P R Menezes; E Ribeiro; D C P Geiger; Y Mikami; M Miyaji; M S Oliveira; A A Barone; A S Levin
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

Review 6.  Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria.

Authors:  Suzanne Geerlings; Vivian Fonseca; David Castro-Diaz; James List; Shamik Parikh
Journal:  Diabetes Res Clin Pract       Date:  2014-01-08       Impact factor: 5.602

7.  The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing.

Authors:  S E Tebbs; A M Gonzalez; R M Wilson
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

8.  Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics.

Authors:  R Colodner; Y Nuri; B Chazan; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-21       Impact factor: 3.267

Review 9.  Candiduria: a review of clinical significance and management.

Authors:  Zakeya Abdulbaqi Bukhary
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-05

10.  Comparison and correlation of candidal colonization in diabetic patients and normal individuals.

Authors:  Bakthavatchalam Pallavan; Venkatapathy Ramesh; Balamurali Pennagaram Dhanasekaran; Nirima Oza; Sudip Indu; Vasupradha Govindarajan
Journal:  J Diabetes Metab Disord       Date:  2014-06-04
View more
  6 in total

1.  Prevalence, Molecular Identification, and Genotyping of Candida Species Recovered from Oral Cavity among Patients with Diabetes Mellitus from Tehran, Iran.

Authors:  Narges Zarei; Maryam Roudbary; Shahla Roudbar Mohammadi; André Luis Dos Santos; Fatemeh Nikoomanesh; Rasoul Mohammadi; Bahador Nikoueian Shirvan; Sanaz Yaalimadad
Journal:  Adv Biomed Res       Date:  2022-04-29

2.  High prevalence of candiduria due to non-albicans Candida species among diabetic patients: A matter of concern?

Authors:  Alireza Esmailzadeh; Hossein Zarrinfar; AbdolMajid Fata; Tanuka Sen
Journal:  J Clin Lab Anal       Date:  2017-10-27       Impact factor: 2.352

3.  High prevalence of asymptomatic nosocomial candiduria due to Candida glabrata among hospitalized patients with heart failure: a matter of some concern?

Authors:  Seyed Reza Aghili; Mahdi Abastabar; Ameneh Soleimani; Iman Haghani; Soheil Azizi
Journal:  Curr Med Mycol       Date:  2020-12

4.  Evaluation of a Novel Laboratory Candiduria Screening Protocol in the Intensive Care Unit.

Authors:  Zhengxin He; Chang Su; Yuwang Bi; Yan Cheng; Daxin Lei; Fukun Wang
Journal:  Infect Drug Resist       Date:  2021-02-10       Impact factor: 4.003

Review 5.  Case Report: Diabetic urinary auto-brewery and review of literature.

Authors:  Abdulrahman A Alduraywish
Journal:  F1000Res       Date:  2021-05-20

6.  Cell wall mannan of Candida krusei mediates dendritic cell apoptosis and orchestrates Th17 polarization via TLR-2/MyD88-dependent pathway.

Authors:  Thu Ngoc Yen Nguyen; Panuwat Padungros; Panachai Wongsrisupphakul; Noppadol Sa-Ard-Iam; Rangsini Mahanonda; Oranart Matangkasombut; Min-Kyung Choo; Patcharee Ritprajak
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.